MORF4L2
Mortality factor 4-like protein 2
Also known as: KIAA0026, MO4L2_HUMAN, MRGX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15014
- Gene
- MORF4L2
- Ensembl
- ENSG00000123562
- Chromosome
- X
- Canonical length
- 288 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Involved in positive regulation of double-strand break repair via homologous recombination and regulation of cell cycle. Located in nucleolus; nucleoplasm; and plasma membrane. Part of NuA4 histone acetyltransferase complex and nucleosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>Q15014|MORF4L2
1 MSSRKQGSQP RGQQSAEEEN FKKPTRSNMQ RSKMRGASSG KKTAGPQQKN LEPALPGRWG
61 GRSAENPPSG SVRKTRKNKQ KTPGNGDGGS TSEAPQPPRK KRARADPTVE SEEAFKNRME
121 VKVKIPEELK PWLVEDWDLV TRQKQLFQLP AKKNVDAILE EYANCKKSQG NVDNKEYAVN
181 EVVAGIKEYF NVMLGTQLLY KFERPQYAEI LLAHPDAPMS QVYGAPHLLR LFVRIGAMLA
241 YTPLDEKSLA LLLGYLHDFL KYLAKNSASL FTASDYKVAS AEYHRKALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MORF4L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 359 nTPM
Expression across tissuesHPA
Tissue
- ovary: 359 nTPM
- smooth muscle: 307 nTPM
- endometrium: 260 nTPM
- blood vessel: 254 nTPM
- hypothalamus: 242 nTPM
- cervix: 234 nTPM
Single-cell type
- extravillous trophoblasts: 1,860 nCPM
- decidual stromal cells: 986 nCPM
- migrating cytotrophoblasts: 947 nCPM
- syncytiotrophoblasts: 798 nCPM
- ovarian stromal cells: 768 nCPM
- peritubular myoid cells: 695 nCPM
Immune cell
- plasmacytoid DC: 70 nTPM
- basophil: 55 nTPM
- non-classical monocyte: 48 nTPM
- MAIT T-cell: 47 nTPM
- NK-cell: 46 nTPM
- intermediate monocyte: 44 nTPM
Brain region
- hypothalamus: 255 nTPM
- cerebral cortex: 224 nTPM
- pons: 218 nTPM
- choroid plexus: 199 nTPM
- midbrain: 194 nTPM
- basal ganglia: 189 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 1.76
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- DNA repair
- positive regulation of DNA-templated transcription
- positive regulation of double-strand break repair via homologous recombination
- regulation of apoptotic process
- regulation of cell cycle
- regulation of double-strand break repair
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MORF4L2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MORF4L2 as an antibody target. Whether an autoantibody or antibody against MORF4L2 could matter depends on whether native MORF4L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MORF4L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MORF4L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...